Evidence map›Paper›PMID 40806659›Full record

ArticleInternational journal of molecular sciences2025

Suppression of Cytosolic Phospholipase A2 in the Ventromedial Hypothalamus Induces Hyperphagia and Obesity in Male Mice.

Takashi Abe, Taiga Ishimoto, Yudai Araki, Ziwei Niu, Changwen Li, Jinxiao He, Samson Ngurari, Chitoku Toda

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takashi AbeDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.ORCID 0000-0001-7411-6856
Taiga IshimotoDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.ORCID 0009-0003-2775-5892
Yudai ArakiDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.
Ziwei NiuDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.
Changwen LiDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.
Jinxiao HeDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.
Samson NgurariDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.
Chitoku TodaDepartment of Neuroscience for Metabolic Control, School of Medicine, Kumamoto University, Kumamoto 860-8555, Japan.ORCID 0000-0002-1641-6217

Funding

Akiyama Life Science Foundation NAAstellas Foundation for Research on Metabolic Disorders NADaiichi Sankyo Foundation of Life Science NAJapan Agency for Medical Research and Development JP21gm6510009h0001, JP22gm6510009h9901, 23gm6510009h9903, 24gm6510009h9904Japan Society for the Promotion of Science 21H02352, 21K18275T, 23H00512Narishige Neuroscience Research Foundation NASuzuken Memorial Foundation NATakeda Science Foundation NAUehara Memorial Foundation NA
6 · The paper itself

Abstract

We recently reported that phospholipase A2 (PLA2)-mediated production of prostaglandins within the ventromedial hypothalamus (VMH) plays a critical role in systemic glucose homeostasis. However, the role of PLA2 in the VMH in regulating food intake is still unclear. Here, we attempted to investigate the role of PLA2 in regulating food intake and body weight in male mice. We injected an adeno-associated virus encoding short hairpin RNA (AAV-shRNA) targeting cytosolic phospholipase A2 (shPla2g4a) into the VMH. We assessed food intake, body weight, oxygen consumption, glucose tolerance, and insulin sensitivity. Three weeks after the AAV injection, the shPla2g4a group exhibited increased food intake and body weight gain compared to controls (shSCRM). Energy expenditure, oxygen consumption, and respiratory quotient (RQ) were comparable between groups. Our findings suggest that the cPLA2-mediated pathway in the VMH is critical for feeding behavior and maintaining energy homeostasis. Further investigation is needed to elucidate the underlying mechanisms.

Indexed as

Group IV Phospholipases A2HyperphagiaObesityPhospholipases A2, CytosolicVentromedial Hypothalamic NucleusAnimalsBody WeightEatingEnergy MetabolismInsulin ResistanceMaleMiceMice, Inbred C57BLOxygen ConsumptionRNA, Small InterferingGroup IV Phospholipases A2Phospholipases A2, CytosolicRNA, Small Interferingappetitebody weightovereatingphospholipidprostaglandinsVMH

Identifiers

PMID40806659
PMCPMC12347649

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.